Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Ahmed awarded funding to create world’s first ovarian cancer prevention vaccine

NDWRH

Researchers at the MRC WIMM have been awarded up to £600,000 from Cancer Research UK (CRUK) to create the world’s first vaccine to prevent ovarian cancer.

The Oxford Omics Data Camp 2024: Spatial Transcriptomics

The MRC WIMM Centre for Computational Biology recently hosted the inaugural Oxford Omics Data Camp at Jesus College. The camp featured cutting-edge discussions, hands-on workshops and a two-day hackathon.

Researchers develop new tool to better predict AML outcomes in older patients

In a study published in the Journal of Clinical Oncology, an international research team has used machine learning to improve risk stratification for patients over 60 diagnosed with acute myeloid leukaemia, an aggressive type of blood cancer.

Senior Fellowship awarded to Beth Psaila

MRC MHU RDM

Congratulations to Beth Psaila, who has been awarded a Senior Fellowship funded by Cancer Research UK in partnership with Rosetrees Trust.

Of Mice and Men - Researchers demonstrate evolutionary conservation of blood stem cell subtypes

MRC MHU OCH RDM

Researchers from the MRC Molecular Haematology Unit (MHU) have shown that blood stem cell subtypes found in mice also exist in humans. This provides important information for research into therapies to alleviate the negative effects of aging.

MRC WIMM Researchers at IF Oxford - book now

IF Oxford returns as a digital and in-real-life science and ideas Festival with events running throughout October 2024.

18 teams in the MRC WIMM receive LEAF Sustainability awards

Department of Oncology MRC MHU MRC TIDU NDCN RDM

The Laboratory Efficiency Assessment Framework (LEAF) aims to support research laboratories to embed sustainability into their work.

Yellowstone Biosciences spinout launches to advance cutting-edge cancer therapies

Innovation MRC MHU RDM

Yellowstone Biosciences, a biotechnology spinout, has launched to pioneer new cancer treatments using advanced T-cell therapies based on groundbreaking research from the MRC Weatherall Institute of Molecular Medicine at the University of Oxford.

Professor Valentine Macaulay, 1955-2024

Department of Oncology

We are deeply saddened to hear of the passing of our former colleague Valentine (Val) Macaulay from cancer on Tuesday 2nd July.

WIMM Day 2024

Department of Oncology MRC MHU MRC TIDU Paediatrics RDM

On Thursday 20th June 2024, the MRC Weatherall Institute of Molecular Medicine came together to share their research and celebrate the MRC WIMM community at Saïd Business School for WIMM Day 2024.

New Sculpture Unveiled at the MRC WIMM

MRC MHU

On Wednesday 29th May, a small group of institute members gathered to witness the unveiling of a new ceramic sculpture of a cell made by former MRC WIMM Group Leader Veronica Dudley (Buckle).

Adam Mead Elected as Fellow of the Academy of Medical Sciences

MRC MHU RDM

Congratulations to Professor Adam Mead, who the Academy of Medical Sciences has elected to its fellowship.

Load More